Zhilin Group begins commercialization of yam bioactive nutrition tablets

This product is suitable for menopausal women with symptoms

HongKong based Zhilin Group, a biopharmaceutical company committed to developing innovative therapies to address global unmet medical needs, announces products with its dietary supplements, this product is suitable for menopausal women with symptoms. 

The supplement is made of extracted yam powder containing DOI (a biologically active ingredient), which is a non-hormonal product launched by the Zhilin Group in view of the increasing consumer pursuit and attention to nutritional products. It is estimated that there will be 1.2 billion women in menopause or postmenopause worldwide by 2030 . The global health product market for women’s menopause symptoms is expected to exceed $ 50 billion in 2025, with a compound growth rate of 16.4% in 2016-2025  . The dietary supplement will first be commercialized and sold in Hong Kong; the company is seeking relevant regulatory permits to sell the product in other major jurisdictions.

As part of the commercialization, Zhilin Group signed a regional distribution agreement with Wantian Tea Company Limited through its wholly-owned subsidiary Nativus Life Sciences Limited. The group company is headquartered in Hong Kong and the company operates a variety of household brands, including Lu Yu® tea bags And other health related products.

Through Wantian Tea, Zhilin Group can bring its products to a wider consumer base in the sales area. Zhilin Group’s yam bioactive health food tablet has begun production in Canada and will soon be sold under the NativusWell ™ brand.